Back
Joseph Turk
Chief Executive Officer of Care Enablement, Fresenius Medical Care AG

Field Notes Ep. 20 | What’s Next for NxStage with Joe Turk

🎥 Jun 01, 2021 📺 Fresenius Medical Care North America ⏱ 20m
Last year in the U.S., home dialysis reached 14% of all treatments by Fresenius Kidney Care, and home hemodialysis with the ...
Watch on YouTube
Transcript (21 segments)
B
Brad Puffer0:03
Welcome everyone to this episode of Field Notes. I'm Brad Puffer, your host. Today we're looking at how the merger with NextStage Medical is evolving home dialysis and critical care. Home dialysis reached 14% of Fresenius Kidney Care treatments, and home hemodialysis with the NextStage system grew 37%. The NextStage team has also responded to COVID and natural disasters. We're excited to welcome Joe Turk, former president of NextStage and now president of home and critical care therapies for Fresenius Medical Care North America. Joe, welcome to Field Notes.
J
Joseph Turk1:10
Hey Brad, it's good to be here. Thanks for inviting me.
B
Brad Puffer1:14
Well, I wanted to start with your thoughts when you were at NextStage building the company from the ground up. Could you have ever imagined being part of Fresenius Medical Care, and what have been your biggest surprises since the two companies came together?
J
Joseph Turk1:31
It depends on whether you were in the moment or in your heart or thinking about it in your head. In the moment, we were so focused on building the business and bringing new therapies to patients at home and in the hospital that we didn't have a lot of time to think about it. When you step back, the combination of NextStage and Fresenius was logical — complementary, with NextStage strong in home hemo and critical care, and Fresenius strong in in-center and PD. The biggest surprise was the incredible alignment in mission and philosophy, despite how different the companies were in size and maturity.
B
Brad Puffer2:44
When you look back over those two years, what are the two or three things you're most proud of?
J
Joseph Turk2:47
First, the rapid and continued acceleration of home dialysis training. Many more people are realizing the benefit of home hemodialysis. Second, advancing tools like the TCU, staffing, connected health, and telemedicine to take home to the next level. Third, I'm really proud of how we as an organization responded to the pandemic — helping patients in ICUs across the country and patients at home.
B
Brad Puffer3:38
Let's dig into that growth rate. Did it exceed your expectations, and what do you think is causing it?
J
Joseph Turk3:49
We were always optimistic about home hemodialysis potential. Patients told us how it changes lives, and there were markets with high and low home adoption, so room to grow. When the time came, it took all hands on deck — education teams, clinical training, manufacturing, supply chain, and technical support. I'm proud of what the team accomplished. The growth surprised us all in a good way. The biggest driver was clear alignment from the start that growth was possible and a priority. The NextStage merger was a catalyst, and changes in government programs like ETC and CKCC models, plus competition, will continue to drive growth.
B
Brad Puffer5:23
I wanted to talk about the pandemic. How did NextStage and your team play a role, and why was the NextStage system a great option for hospitals treating patients?
J
Joseph Turk5:45
The NextStage system's flexibility — portable, deployable in different parts of the hospital, uses bagged fluids, and delivers a wide range of therapies — made it a great option. When the pandemic hit, we identified hot spots, got machines and supplies to hospitals, and helped create capacity by training hospitals on different ways to use the machines. We collaborated with Fresenius Kidney Care and inpatient services to get staffing to the right places, especially early in New York City. We also created the National Renal Intensive Care Reserve to rapidly move machines and supplies as hot spots shifted. I was proud of how the team identified and reacted quickly, and the feedback from physician partners and customers was tremendous.
B
Brad Puffer8:44
Absolutely a huge response by everybody. I wanted to turn to operational things like connected health and transitional care units. What are the most important initiatives that have taken off?
J
Joseph Turk9:04
Connected health is hugely important for home dialysis — it makes it easier for staff and patients to communicate, improves care through better fluid management and training follow-up. Most patients are already connected via Next to Me, the Hub, or Connexus for PD, and we'll keep improving functionality. Transitional care units are a game changer — half of patients start dialysis unplanned, so the TCU offers a simpler, more focused start. Over 40% of patients who go through TCUs choose a home modality, and it gives better chance of permanent access and staying out of the hospital. These are areas we'll focus on in 2021 and beyond.
B
Brad Puffer11:37
I want to get back to the NextStage system. We talked about the merger and growth, and now DaVita is investing heavily in the system too. That must feel really good.
J
Joseph Turk11:59
Definitely. NextStage has worked with DaVita for a long time, and it's nice to see them committing to home hemodialysis and PD with our product. With both Fresenius Kidney Care and DaVita expanding home programs, that's good for patients. What makes the NextStage system unique is its size and portability — it's the only machine small enough to take on the road or even a plane. Most patients travel, and it's the only system that can do that. We've worked with the FDA for solo and nocturnal dialysis, and it's the only system that can use both on-site produced dialysate and bag dialysate when water is unavailable, which is critical for travel and emergencies. The support — clinical education, technical support, customer supply chain — also makes it competitive.
B
Brad Puffer15:02
That's a good point about support. I wanted to expand on the bag dialysate situation. During the Texas water crisis, the NextStage team really rose to the occasion, helping home patients never miss a treatment and responding to hospitals and in-center units.
J
Joseph Turk15:47
The biggest challenge in dialysis is water. Without water, you can't make dialysate. The NextStage system's ability to use bag fluid is key. In Texas, we saw how severe it was, but these things happen often — water main breaks, algae blooms. We make sure home patients have extra supplies of cartridges and bag fluid. We also helped dialysis centers without water and hospitals with our technology. Hats off to the team for making a big difference.
B
Brad Puffer17:35
As we finish up, what is next for the NextStage system within Fresenius Medical Care North America? How will home dialysis growth continue, and how will the team be part of that?
J
Joseph Turk17:53
I truly believe we're just at the start. NextStage will continue to innovate to make dialysis simpler and more doable at home — through interface improvements, building on our technology, and connected health via the Next to Me platform. We're also investing in how we deliver dialysate to make the system even more flexible. There are opportunities to share best practices between the services side, dialysis centers, and home programs. The sky's the limit.
B
Brad Puffer19:24
Well, it will be great to see how it accelerates over the next few years. This has been a great conversation, Joe. Thank you so much for joining us.
J
Joseph Turk19:34
Hey Brad, always happy to talk about home dialysis. I'm excited about it — it's a chance to do a really fantastic thing for patients.
B
Brad Puffer19:42
A note to our listeners: The NextStage system is a prescription device with risks including high blood pressure, fluid overload, low blood pressure, heart issues, and vascular access complications. Patients should consult their doctor to understand risks and responsibilities. For a full list, visit nextstage.com. Don't forget, you can find Field Notes on the Apple Store or Google Play or at fncna.com. Until next time, I'm Brad Puffer, and you have been listening to Field Notes by Fresenius Medical Care. Take care, everyone.